Work

A phase I/II study of safety/efficacy using lurbinectedin, combined with ipilimumab, and nivolumab, for advanced soft tissue sarcomas (NCT05876715).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.tps11599

Authors: Samantha Jeffrey, Sant P. Chawla, Oliver Davidorf, Sarah Lande, Allyssa Lingad, Vanessa Xayasak, Jason Ballon, Ania M. Moradkhani, Ted Kim, Victoria S. Chua-Alcala, Neal Shiv Chawla, Erlinda Maria Gordon

Institution: Sarcoma Oncology Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Jazz Pharmaceuticals

OpenAlex ID: W7162698515

Cites:

Cited by:

Related to: